BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 29242609)

  • 1. Automating drug discovery.
    Schneider G
    Nat Rev Drug Discov; 2018 Feb; 17(2):97-113. PubMed ID: 29242609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Intelligence for Autonomous Molecular Design: A Perspective.
    Joshi RP; Kumar N
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal chemistry in drug discovery in big pharma: past, present and future.
    Campbell IB; Macdonald SJF; Procopiou PA
    Drug Discov Today; 2018 Feb; 23(2):219-234. PubMed ID: 29031621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidics contribution to pharmaceutical sciences: From drug discovery to post marketing product management.
    Nys G; Fillet M
    J Pharm Biomed Anal; 2018 Sep; 159():348-362. PubMed ID: 30032003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated and enabling technologies for medicinal chemistry.
    Nichols PL
    Prog Med Chem; 2021; 60():191-272. PubMed ID: 34147203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
    Meanwell NA
    Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic synthesis provides opportunities to transform drug discovery.
    Blakemore DC; Castro L; Churcher I; Rees DC; Thomas AW; Wilson DM; Wood A
    Nat Chem; 2018 Apr; 10(4):383-394. PubMed ID: 29568051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
    Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
    Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding the sweet spot: the role of nature and nurture in medicinal chemistry.
    Hann MM; Keserü GM
    Nat Rev Drug Discov; 2012 Apr; 11(5):355-65. PubMed ID: 22543468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.
    Thomford NE; Senthebane DA; Rowe A; Munro D; Seele P; Maroyi A; Dzobo K
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active-learning strategies in computer-assisted drug discovery.
    Reker D; Schneider G
    Drug Discov Today; 2015 Apr; 20(4):458-65. PubMed ID: 25499665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern drug discovery technologies: opportunities and challenges in lead discovery.
    Guido RV; Oliva G; Andricopulo AD
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the 'organizational factor' on compound quality in drug discovery.
    Leeson PD; St-Gallay SA
    Nat Rev Drug Discov; 2011 Sep; 10(10):749-65. PubMed ID: 21959288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting physical to fix pharma.
    Connelly PR; Vuong TM; Murcko MA
    Nat Chem; 2011 Aug; 3(9):692-5. PubMed ID: 21860457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-on drugs: how far should chemists look?
    Giordanetto F; Boström J; Tyrchan C
    Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can biochemistry drive drug discovery beyond simple potency measurements?
    Chène P
    Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.